Astrana Health, Inc. (NASDAQ:ASTH) Shares Sold by Sei Investments Co.

Sei Investments Co. lessened its holdings in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 23.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 18,258 shares of the company’s stock after selling 5,461 shares during the period. Sei Investments Co.’s holdings in Astrana Health were worth $576,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Handelsbanken Fonder AB grew its holdings in shares of Astrana Health by 4.7% during the fourth quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company’s stock worth $281,000 after purchasing an additional 400 shares during the last quarter. Swiss National Bank grew its stake in Astrana Health by 1.1% during the 4th quarter. Swiss National Bank now owns 88,444 shares of the company’s stock worth $2,789,000 after buying an additional 1,000 shares during the last quarter. KBC Group NV increased its position in Astrana Health by 108.4% during the fourth quarter. KBC Group NV now owns 2,530 shares of the company’s stock worth $80,000 after buying an additional 1,316 shares during the period. Moran Wealth Management LLC lifted its stake in Astrana Health by 21.5% in the fourth quarter. Moran Wealth Management LLC now owns 7,944 shares of the company’s stock valued at $250,000 after buying an additional 1,404 shares during the last quarter. Finally, Linden Thomas Advisory Services LLC boosted its holdings in shares of Astrana Health by 23.3% in the fourth quarter. Linden Thomas Advisory Services LLC now owns 15,247 shares of the company’s stock valued at $481,000 after acquiring an additional 2,883 shares during the period. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Analyst Upgrades and Downgrades

ASTH has been the subject of a number of recent research reports. Robert W. Baird decreased their price target on shares of Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a research note on Monday, March 3rd. Bank of America lowered their price target on Astrana Health from $55.00 to $49.00 and set a “buy” rating on the stock in a report on Tuesday, March 4th. Macquarie raised Astrana Health to a “hold” rating in a research note on Monday, December 16th. Truist Financial lowered their target price on Astrana Health from $50.00 to $46.00 and set a “buy” rating on the stock in a research note on Tuesday, March 18th. Finally, Stifel Nicolaus cut their price target on Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a research note on Thursday, February 20th. Three equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $53.29.

Astrana Health Stock Performance

Astrana Health stock opened at $31.93 on Thursday. The stock has a fifty day moving average price of $32.55 and a 200 day moving average price of $40.35. Astrana Health, Inc. has a 52 week low of $23.12 and a 52 week high of $63.20. The firm has a market capitalization of $1.60 billion, a P/E ratio of 24.56, a PEG ratio of 1.37 and a beta of 1.04. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.37). The company had revenue of $665.21 million during the quarter, compared to analyst estimates of $617.24 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. Equities research analysts anticipate that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.